A recent decree allows for the maintaining of a compassionate use authorisation granted for medicines subject to very early clinical studies, in the absence of submission for an early access authorisation. The authorisation can be maintained for a maximum period of one year to ensure continuity of care for specific patients. Free Practical Law trial To access this resource, sign up for a free trial of Practical Law. Already registered? Sign in to your account. Contact us